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Background: The beneﬁcial effects of ginsenoside species have been well demonstrated in a number of
studies. However, the function of ginsenoside Ro (GRo), an oleanane-type saponin, has not been sufﬁ-
ciently investigated. Thus, the aim of the present study was to investigate the anti-inﬂammatory effects
of GRo in vitro using the Raw 264.7 mouse macrophage cell line treated with lipopolysaccharide (LPS),
and to clarify the possible mechanism of GRo involving heme oxygenase-1 (HO-1), which itself plays a
critical role in self-defense in the presence of inﬂammatory stress.
Methods: Raw 264.7 cells were pretreated with GRo (up to 200mM) for 1 h before treatment with 1 mg/
mL LPS, and both cell viability and inﬂammatory markers involving HO-1 were evaluated.
Results: GRo signiﬁcantly increased cell viability in a dose dependent manner following treatment with
LPS, and decreased levels of reactive oxygen species and nitric oxide. GRo decreased inﬂammatory cy-
tokines such as nitric oxide synthase and cyclooxygenase-2 induced by LPS. Moreover, GRo increased the
expression of HO-1 in a dose dependent manner. Cotreatment of GRo with tin protoporphyrin IX, a
selective inhibitor of HO-1, not only inhibited upregulation of HO-1 induced by GRo, but also reversed the
anti-inﬂammatory effect of GRo in LPS treated Raw 264.7 cells.
Conclusion: GRo induces anti-inﬂammatory effects following treatment with LPS via upregulation of
HO-1.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inﬂammation is a complex biological response against harmful
stimuli and plays a critical role in immune defense under various
external and internal pathogens [1]. Harmful stimuli such as lipo-
polysaccharides (LPS), a toxicmolecule derived from gram-negative
bacteria cell walls, activate macrophages to release various proin-
ﬂammatory molecules, including nitric oxide synthase (NOS), nitric
oxide (NO), and cytokines including cyclooxygenase 2 (COX-2)
[2]. NO has a critical role in various diseases involving the immune
system such as atherosclerosis, auto-immune disease, and neuro-
degenerative disorders [3]. NO is produced by inducible NOSnimal Medicine, College of Veterin
ht  2015, The Korean Society of G
c-nd/4.0/).(iNOS), which is the major form induced in response to inﬂam-
matory stimuli including LPS [4]. Likewise, COX-2 is responsible
for the production of numerous prostaglandins and reactive oxygen
species (ROS) at sites of inﬂammation [5,6]. Therefore, a number
of studies concerning the development of anti-inﬂammatory
agents have proposed targeting the production of harmful
stimuli as a potential strategy for the treatment of inﬂammatory
diseases.
Heme oxygenase (HO) has three isoforms, namely, HO-1, HO-2,
and HO-3, that serve as cyto-protective enzymes that catalyze
heme degradation, producing carbon monoxide (CO), iron, and
biliverdin as the ﬁnal products [7,8]. Among the isoforms of HO,ary Medicine, Chonbuk National University, 664-14, Duckjin-Dong, Jeonju, Jeonbuk,
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
J Ginseng Res 2015;39:365e370366HO-1 is the major functional protein induced by various stimuli
including UV radiation and oxidative stress [9]. Previous studies
have examined the relationship between HO-1 and LPS as a po-
tential strategy formediating anti-inﬂammatory effects [10,11]. As a
result, it has been established that HO-1 plays an important role in
regulating immune responses.
The ginseng plant has been traditionally used as a medicine in
East Asia [12]. Numerous alternative and complementary medicine
studies have examined the function of ginseng. Ginseng contains
various bioactive components including ginsenoside, poly-
acetylenes, polyphenolic compounds, and acidic polysaccharides
[13]. Previous studies have shown that the most functional mole-
cules in ginseng are ginsenoside, which are a speciﬁc type of tri-
terpene saponin [13,14]. Ginsenoside Ro (GRo), which possesses an
oleanane-type aglycone, is themajor ginsenoside constituent in the
Panax ginseng rhizome [15]. However, only one report of the anti-
inﬂammatory effects of GRo has been published, and was limited
to the effects of GRo on suppression of inﬂammatory symptoms in
arthritic rats [16]. However, there have been no studies that have
looked at the underlying mechanisms of GRo and its anti-
inﬂammatory effects in Raw 264.7 cells, which are a model of im-
mune macrophage cells. Thus, the aim of the present study was to
explore the anti-inﬂammatory effects of GRo associated with the
HO-1 pathway in Raw 264.7 cells treated with LPS.
2. Materials and methods
2.1. Chemicals
GRo was purchased from the Ambo Institute (Daejeon, Korea).
LPS, Griess reagent, and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). 20,70-dichlordihydroﬂuorescin diac-
etate (DCF-DA) was purchased from Invitrogen (Carlsbad, CA, USA).
Tin protoporphyrin IX (SnPP), an inhibitor of HO activity, was
purchased from Porphyrin Products (Logan, UT, USA). Primary an-
tibodies, including HO-1, COX-2, iNOS, and the appropriate sec-
ondary antibodies used for immunoblotting analysis, were
purchased from Cell Signaling Technology (Danvers, MA, USA). Cell
culture medium and other in vitro ingredients were purchased from
Hyclone (Logan, UT, USA).
2.2. Cell culture and treatments
The Raw 264.7 mouse macrophage cell line was obtained from
the Korean Cell Line Bank (KCLB; Seoul, Korea). Cells were cultured
at 37C under a humidiﬁed, 5% CO2 atmosphere in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% Fetal
bovine serum (FBS), 100 U/mL of penicillin, and 100 mg/mL of
streptomycin. In all experiments, cells were allowed to acclimate
for 24 h before treatment. After reaching conﬂuence, cells were
incubated with GRo for 1 h at different concentrations up to 200mM
followed by 1 mg/mL LPS for 24 h. In some experiments, Raw 264.7
cells were also pretreated with 10mM SnPP for 1 h prior to GRo and/
or LPS treatment.
2.3. Cell viability assay
Cell viability was determined with anMTT assay kit. Brieﬂy, Raw
264.7 cells were plated in 48-well plates at a density of 2.0  104
cells per well, incubated for 24 h, and treated with various con-
centrations of GRo for 24 h. We then investigated how 1 h of pre-
treatment with GRo (50mM, 100mM, and 200mM) affected the
viability of Raw 264.7 cells treated with 1 mg/mL LPS for 24 h. After
the incubation period, 10 mL of MTT reagent was added to each welland incubated for 3 h at 37C in 5% CO2. The resulting formazan
crystals were subsequently dissolved in MTT solubilization solu-
tion. The absorbance was determined at 540 nm using a microplate
reader (Bio-Tek Instruments, Winooski, VT, USA).2.4. Determination of ROS production
ROS production was quantiﬁed by ﬂuorescence using DCF-DA.
Cells were grown in 48-well plates and incubated with the indi-
cated treatments for 3 h. After the incubation period, cells were
washed with phosphate-buffered saline (PBS) and stained with
DCF-DA in PBS for 30 min in the dark. The plates were thenwashed
twice with PBS and extracted with 0.1% Tween-20 in PBS for 10 min
at 37C. Fluorescence was recorded using an excitation wavelength
of 490 nm and an emission wavelength of 525 nm.2.5. Determination of NO production
Production of NO was determined by measuring accumulated
levels of nitrite, an indicator of NO in the supernatant, after treat-
ment with LPS for 24 h under the indicated conditions. The nitrite
concentration in the supernatant of cultured medium was
measured using Griess reagent. Brieﬂy, samples were mixed with
equal volumes of Griess reagent (1% sulfanilamide, 0.1% N-1-
naphthylenediamine dihydrochloride, and 2.5% phosphoric acid)
and incubated for 20 min at room temperature. Absorbance was
then measured at 540 nm on a microplate reader.2.6. Immunoblotting analysis
Cells were washed three times with phosphate buffered saline
(PBS), scraped off plates, and lysed with lysis buffer (1% Triton X-
100, 1% deoxycholate). The protein concentration of lysates was
determined using Bradford reagent (Bio-Rad Laboratories, Hercu-
les, CA, USA), and equal amounts of protein were separated elec-
trophoretically using 10% sodium dodecyl sulfateepolyacrylamide
gel electrophoresis and transferred to polyvinylidenediﬂuoride
membranes (Bio-Rad Laboratories). Membraneswere blocked in 5%
skim milk in PBS and incubated with primary antibodies against
HO-1, COX-2, iNOS, and b-actin diluted 1:500 in 1% skimmilk in PBS
overnight at 4C. The blots were then incubated with a peroxidase-
conjugated goat antirabbit IgG diluted 1:5000 for 1 h. Protein bands
were visualized with SuperSignal West Dura Extended Duration
Substrate (Thermo Scientiﬁc, San Jose, CA, USA) and analyzed using
a chemiImager analyzer system (Alpha Innotech, San Leandro, CA,
USA).2.7. Cell morphology observations
Raw 264.7 cells in 48-well plates were treated with the indi-
cated conditions for 24 h. After incubation, plates were observed
and photographed using an Observer A1 microscope at 100
magniﬁcation (Carl Zeiss, München, Germany).2.8. Statistical analyses
Results are presented as the mean  standard error. Data were
analyzed using Student t test (for 2 groups), one-way analysis of
variance, and Tukey test (for > 2 groups). A p value < 0.05 was
considered statistically signiﬁcant. All analyses were performed
using the SPSS version 13.0 for Windows (SPSS Inc., Chicago, IL,
USA).
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3.1. GRo increases cell viability attenuated by LPS
MTT assay was performed to determine the effect of GRo on cell
viability in LPS-treated Raw 264.7 cells. To assess the toxicity of GRo
in Raw 264.7 cells, they were ﬁrst treated with various concen-
trations (10mM, 50mM, 100mM, and 200mM) of GRo for 24 h. GRo
exhibited no signiﬁcant dose dependent toxicity (Fig. 1A). We next
determined the effect of GRo on both cell viability and ROS levels, a
marker of oxidative stress, following treatment with 1 mg/mL LPS
(Fig. 1B, 1C). LPS reduced cell viability by w70% compared with
nontreated controls. As shown in Fig. 1B, pretreatment with 100mM
and 200mMGRo for 1 h prior to 1 mg/mL LPS incubation for 24 h led
to a signiﬁcant increase in cell viability. The changes in ROS levels
and NO production were consistent with the effects of GRo on
viability (Fig. 1C, 1D). Together, these results suggested that GRo
increases cell viability in a dose dependent manner while
decreasing ROS and NO production induced by LPS.
3.2. GRo inhibits proinﬂammatory cytokines in LPS-induced Raw
264.7 cells
To examine the anti-inﬂammatory effects of GRo on LPS-
induced inﬂammation, immunoblotting was performed with cells
pretreated with various concentration of GRo for 1 h followed by
LPS. As shown in Fig. 2A, GRo signiﬁcantly reduced protein
expression of iNOS induced by LPS. Moreover, protein expression of
COX-2 was signiﬁcantly reduced in GRo-treated cells induced by
LPS (Fig. 2B). These results showed that the anti-inﬂammatory ef-
fects of GRo were associated with a marked reduction in levels of
proinﬂammatory cytokines induced by LPS.
3.3. GRo induces upregulation of HO-1 in Raw 264.7 cells
To identify the anti-inﬂammatory mechanism of GRo, we ﬁrst
conﬁrmed the expression of HO-1, a candidate for the anti-
inﬂammatory effects of GRo, in Raw 264.7 cells. Speciﬁcally, we
examined whether induction of HO-1 is involved in the anti-
inﬂammatory properties of GRo. As shown in Fig. 3A, GRo
increased HO-1 expression in a dose dependent manner, and cells
treated with 200mM GRo exhibited signiﬁcantly increased expres-
sion of HO-1. In addition, we investigatedwhether GRo induces HO-
1 expression in the presence of LPS. Cells were pretreated with
various concentrations of GRo for 1 h prior to LPS treatment for
24 h. GRo signiﬁcantly increased HO-1 expression despite theFig. 1. Effects of GRo on cell viability and production of ROS and NO in LPS-induced Raw 2
viability was determined. Next, cells were pretreated with GRo for 1 h and then incubated w
were pretreated with GRo for 1 h followed by 1 mg/mL LPS for 3 h and (C) ROS production w
viability assay. Data are presented as mean  SEM (n ¼ 3). *p < 0.05 and **p < 0.01, as co
senoside Ro; LPS, lipopolysaccharide; NO, nitric oxide; ROS, reactive oxygen species.presence of LPS (Fig. 3B). Importantly, these results suggested the
possibility that HO-1 mediates the anti-inﬂammatory effect of GRo.3.4. GRo inhibits proinﬂammatory cytokines via HO-1 induction
To investigate the anti-inﬂammatory effects of GRo via HO-1
induction, we used SnPP, a selective inhibitor of HO activity [17].
SnPP induces light oxidation processes followed by inhibit meta-
bolism of porphyrin. As a result, essential prosthetic factor, such as
heme was not synthesized and enzyme activity of HO-1 was also
decreased. Speciﬁcally, cells were pretreated with 10mM SnPP for
1 h prior to sequential treatment with GRo and then LPS for 24 h.
The expression of HO-1 was signiﬁcantly diminished by SnPP.
Moreover, SnPP signiﬁcantly counteracted HO-1 expression
increased by GRo in the presence of LPS (Fig. 4A). Consistent with
these data, the patterns of iNOS and COX-2 were opposite to that of
HO-1 (Fig. 4B, 4C). Speciﬁcally, cells treated with SnPP alone did not
exhibit signiﬁcant changes in iNOS (Fig. 4B) or COX-2 (Fig. 4C). SnPP
treatment notably counteracted iNOS and COX-2 expression
attenuated by GRo. Taken together, these results suggested that
GRo attenuates proinﬂammatory cytokines by inducing expression
of HO-1.3.5. GRo exerts its anti-inﬂammatory effect via induction of HO-1
Finally, we investigated changes in cell morphology under
different conditions, and examined these changes in the presence
of SnPP and in the context of our previous ﬁndings on cell viability
and ROS. Speciﬁcally, LPS treatment induced morphological
changes in Raw 264.7 cells through generation of spindle shaped
cells and massive clusters. Moreover, LPS signiﬁcantly reduced the
number of attached cells as determined by microscopy, whereas
GRo treatment led to maintenance of normal cell shape and
morphology and also increased the number of adherent cells; SnPP
signiﬁcantly counteracted the effects of GRo (Fig. 5A). Naturally,
results of cell viability, ROS, and NO reﬂected our observations of
cell morphology. As shown in Fig. 5B, SnPP signiﬁcantly inhibited
the increased cell viability facilitated by GRo in the presence of LPS,
whereas ROS and NO assay results exhibited an opposite tendency
consistent with the changes in cell viability (Fig. 5C, 5D). Interest-
ingly, NO productionwas increased in cells treated with SnPP alone
(Fig. 5D), suggesting the possibility that additional factors are
induced by inhibition of HO-1. Taken together, these results sug-
gested that GRo exerts its anti-inﬂammatory effects via induction of
HO-1.64.7 cells. Cells were incubated with GRo up to 200mM for 24 h, after which (A) cell
ith 1 mg/mL LPS for 24 h, after which (B) cell viability was determined. In addition, cells
as examined. (D) NO assay using supernatant from the same samples used for the cell
mpared with the control. #p < 0.05, as compared with LPS treatment alone. GRo, gin-
Fig. 2. Effects of GRo on proinﬂammatory cytokines in LPS-induced Raw 264.7 cells. Cells were pretreated with GRo up to 200mM for 1 h and incubated with 1 mg/mL LPS for 24 h. (A
and B) The protein expression levels of iNOS and COX-2 were determined by immunoblotting analysis. Data are presented as mean  SEM (n ¼ 3). ***p < 0.001, as compared with
the control. #p < 0.05 and ##p < 0.01, as compared with LPS treatment alone. COX-2, cyclooxygenase-2; GRO, ginsenoside Ro; iNOS, inducible NOS; LPS, lipopolysaccharide.
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Ginsenosides are speciﬁc saponin constituents only found in
ginseng. Numerous pharmacological effects of ginsenosides have
been previously reported, including anti-inﬂammation, anticancer,
antiaging, antioxidant, anticarcinogenic, and antihypertension ef-
fects as well as improved blood circulation [12,18e20]. The present
study demonstrated that GRo, one of the major physiologically-
active ingredients in ginseng, protects macrophages against LPS-
induced inﬂammation. Moreover, HO-1 induction was identiﬁed
for the ﬁrst time as the possible underlying mechanism responsible
for the anti-inﬂammatory effects of GRo.
LPS is produced by bacteria as a toxicant and trigger of proin-
ﬂammatory cytokine expression, iNOS, and NO production in
various mammalian cells, including macrophages [21]. To evaluate
the properties of GRo on macrophages, which are major immune
cells associated with inﬂammation, we initially conﬁrmed its ef-
fects on cell viability and production of ROS and NO in LPS-induced
Raw 264.7 cells, which were used as a model of inﬂammatoryFig. 3. Effects of GRo on HO-1 expression in LPS-induced Raw 264.7 cells. Cells were incub
determined by immunoblotting analysis. Cells were pretreated with GRo up to 200mM for
determined by immunoblotting analysis. Data are presented as mean  SEM (n ¼ 3). *p < 0.0
as compared with LPS treatment alone. GRo, ginsenoside Ro; HO-1, heme oxygenase-1; LPSmacrophages. As shown in Fig. 1Be1D, GRo improved the condition
of cells treated with LPS. Accordingly, we conﬁrmed that GRo
affected the expression of proinﬂammatory cytokines at the protein
level. NO can produce other proinﬂammatory cytokines and is a
harmful stimuli in the cell environment. Additionally, COX-2 trig-
gers sustained ROS production and has been shown to be induced
by proinﬂammatory cytokine signaling and iNOS production of NO,
both of which are active inmammalian cells [10]. As shown in Fig. 2,
GRo decreased levels of iNOS and COX-2 expression induced by LPS
in a dose dependent manner. Having shown that GRo facilitates
anti-inﬂammatory effect against LPS, we next attempted to deter-
mine the possible underlying mechanism.
HO-1 is an intrinsic cell-protective enzyme and is expressed in
various cell types. We ﬁrst conﬁrmed the relationship between GRo
andHO-1, the latter of whichwas previously shown to play a critical
role in immune defense against inﬂammation-induced damage in
the body [22]. Speciﬁcally, HO-1 is the inducible isoform of Heme
oxygenase, and exerts signiﬁcant anti-inﬂammatory, antioxidant,
and antiapoptotic effects. With respect to the anti-inﬂammatoryated with GRo up to 200mM for 24 h, and then (A) the protein expression of HO-1 was
1 h and incubated with 1 mg/mL LPS for 24 h. (B) The protein expression of HO-1 was
5, **p < 0.01, and ***p < 0.001, as compared with the control. #p < 0.05 and ##p < 0.01,
, lipopolysaccharide.
Fig. 4. Effects of GRo on the relationship between HO-1 and proinﬂammatory cytokines in LPS-induced Raw 264.7 cells. Cells were pretreated with 10mM SnPP for 1 h prior to
addition of 200mM GRo for 1 h, followed by incubation with 1 mg/mL LPS for 24 h. (A, B, and C) The protein expression of HO-1, iNOS, and COX-2 were determined by immu-
noblotting analysis. Data are presented as mean  SEM (n ¼ 3). *p < 0.05 and ***p < 0.001, as compared with the control. #p < 0.05 and ##p < 0.01, as compared with LPS treatment
alone. þ p < 0.05 and þþ p < 0.01, as compared with cells treated with GRo followed by LPS. GRo, ginsenoside Ro; HO-1, heme oxygenase-1; LPS, lipopolysaccharide.
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deﬁciency of HO-1 leads to severe inﬂammation, whereas HO-1
overexpression leads to enhanced anti-inﬂammatory effects [23e
25]. Moreover, HO-1 expression plays a critical role in preventing
inﬂammation in LPS-induced macrophages [26]. As expected, HO-1
expression was increased by GRo treatment in a dose dependent
manner (Fig. 3A), as well as under LPS-induced inﬂammation
conditions (Fig. 3B). Accordingly, we used SnPP, which is a selective
inhibitor of HO activity, to clarify the relationship between GRo and
its anti-inﬂammatory effects. As shown in Fig. 4A, SnPP treatment
reduced HO-1 expression as expected. Moreover, cells treated with
SnPP exhibited increased levels of proinﬂammatory cytokines due
to inhibition of the downstream effects of GRo on HO-1 expressionFig. 5. Effects of GRo on cell protection in LPS-induced Raw 264.7 cells via HO-1 induction.
incubation with 1 mg/mL LPS for 24 h. (A) Cell morphology was photographed using an Obse
were pretreated with 10mM SnPP for 1 h prior to the addition of 200mM GRo for 1 h, followed
(D) NO assay performed using supernatant from the same samples used for cell viability ass
with the control. #p < 0.05 as compared with LPS treatment alone. þp < 0.05, as compared w
1; LPS, lipopolysaccharide; ROS, reactive oxygen species.(Fig. 4B, 4C). Lastly, SnPP counteracted the effects of GRo on cell
viability and production of ROS and NO in LPS-treated cells (Fig. 5).
In the present study, we examined the potential involvement of
HO-1 in the anti-inﬂammatory effect triggered by GRo. We found
that GRo notably induced HO-l expression in Raw 264.7 cells, and
that this induction of HO-1 correlated with decreased proin-
ﬂammatory molecules such as iNOS and COX-2, and impaired NO
production induced by LPS. Inhibition of HO-1 activity by SnPP
counteracted the effects of GRo, demonstrating that the anti-
inﬂammatory properties of GRo require the activity of HO-1.
Based on these results, our ﬁndings suggest that GRo may serve
as a potential therapeutic strategy to prevent inﬂammation caused
by various harmful immune system stimuli.Cells were pretreated with 10mM SnPP for 1 h prior to 200mM GRo for 1 h, followed by
rver A1 microscope at 100 magniﬁcation, and (B) cell viability was determined. Cells
by incubation with 1 mg/mL LPS for 3 h, after which (C) ROS production was examined.
ays. Data are presented as mean  SEM (n ¼ 3). *p < 0.05 and **p < 0.01, as compared
ith cells treated with GRo followed by LPS. GRo, ginsenoside Ro; HO-1, heme oxygenase-
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